IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $428,000 | +28.5% | 167,318 | -23.1% | 0.00% | – |
| Q2 2016 | $333,000 | -31.6% | 217,445 | -11.5% | 0.00% | – |
| Q1 2016 | $487,000 | -40.0% | 245,825 | -6.4% | 0.00% | -100.0% |
| Q4 2015 | $811,000 | -41.0% | 262,614 | -36.0% | 0.00% | 0.0% |
| Q3 2015 | $1,374,000 | -37.3% | 410,054 | -30.6% | 0.00% | 0.0% |
| Q2 2015 | $2,193,000 | -23.3% | 591,231 | -23.3% | 0.00% | -50.0% |
| Q1 2015 | $2,861,000 | -15.9% | 771,180 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $3,401,000 | +70.6% | 771,180 | -11.4% | 0.00% | +100.0% |
| Q3 2014 | $1,994,000 | -29.0% | 870,629 | -10.1% | 0.00% | -50.0% |
| Q2 2014 | $2,809,000 | -29.1% | 968,484 | -0.3% | 0.00% | -33.3% |
| Q1 2014 | $3,964,000 | -12.5% | 971,650 | -0.7% | 0.00% | -25.0% |
| Q4 2013 | $4,529,000 | +165.0% | 978,091 | -0.4% | 0.00% | +300.0% |
| Q3 2013 | $1,709,000 | +160.1% | 982,055 | -2.1% | 0.00% | 0.0% |
| Q2 2013 | $657,000 | – | 1,003,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,030,604 | $4,285,000 | 0.70% |
| Virtus ETF Advisers LLC | 180,348 | $381,000 | 0.48% |
| Bain Capital Public Equity Management, LLC | 4,564,744 | $9,632,000 | 0.35% |
| Baker Brothers Advisors | 18,315,802 | $38,646,000 | 0.34% |
| Stanley-Laman Group, Ltd. | 483,773 | $1,021,000 | 0.22% |
| FIRST MIDWEST BANK TRUST DIVISION | 493,689 | $1,042,000 | 0.13% |
| GMT CAPITAL CORP | 3,875,546 | $8,178,000 | 0.08% |
| Vident Investment Advisory, LLC | 640,270 | $1,351,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 307,987 | $650,000 | 0.06% |
| Palo Alto Investors LP | 616,355 | $1,301,000 | 0.06% |